Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO2 laser mode

Journal of the European Academy of Dermatology and Venereology

Volumn 32, Issue 11, 2018, Pages 1897-1905

  Genouw, E ^a   Verheire, B ^a   Ongenae, K ^b   De Schepper, S ^b   Creytens, D ^a,b   Verhaeghe, E ^b   Boone, B ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BURNING SENSATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; ERYTHEMA; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPERFICIAL BASAL CELL CARCINOMA; CANCER STAGING; CONFIDENCE INTERVAL; DRUG THERAPY; GAS LASER; LOW LEVEL LASER THERAPY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PARASITOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SKIN TUMOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION;

AGED; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; LASER THERAPY; LASERS, GAS; LOW-LEVEL LIGHT THERAPY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PILOT PROJECTS; PROGNOSIS; RISK ASSESSMENT; SINGLE-BLIND METHOD; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85050480598     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.14989     Document Type: Article

References (41)

1. Marneros A, Bickers D. Nonmelanoma skin cancer. In: Therapy of Skin Diseases a Worldwide Perspective on Therapeutic Approaches and Their Molecular Basis. Berlin, Heidelberg: Springer-Verlag; 2010; 599–620.
2. 2 laser for the treatment of Bowen's disease. Lasers Med Sci 2015; 30: 1505–1510.
3. Shimizu I, Cruz A, Chang K, Dufresne R. Treatment of squamous cell carcinoma in situ: a review. Dermatologic Surg 2011; 37: 1394–1411.
4. Baum C, Bordeaux J, Brown M et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 2018; 78: 540–559.
5. Telfer N, Colver G, Morton C. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35–48.
6. Morton C, Birnie A, Eedy D. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014. Br J Dermatol 2014; 170: 245–260.
7. Choudhary S, Tang J, Elsaie M, Nouri K. Lasers in the treatment of nonmelanoma skin cancer. Dermatol Surg 2011; 37: 409–425.
8. Roozeboom M, Arits A, Mosterd K et al. Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled Trial. J Invest Dermatol 2016; 136: 1568–1574.
9. Morton C, Szeimies R, Sidoroff A, Braathen L. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 536–544.
10. Morton C, Szeimies R, Sidoroff A et al. European dermatology forum guidelines on topical photodynamic therapy. Eur J Dermatol 2015; 25: 296–311.
11. Wang H, Xu Y, Shi J, Gao X, Geng L. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed 2015; 31: 44–53.
12. Roozeboom M, Van Kleef L, Arits A et al. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU). J Am Acad Dermatol 2015; 73: 93–98.
13. Forster B, Klein A, Szeimies R, Maisch T. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium: YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 2010; 19: 806–812.
14. Ali F, Al-Niaimi F. Laser-assisted drug delivery in dermatology: from animal models to clinical practice. Lasers Med Sci 2016; 31: 373–381.
15. Haedersdal M, Erlendsson A, Paasch U, Anderson R. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol 2016; 74: 981–1004.
16. Waibel J, Rudnick A, Shagalov D, Nicolazzo D. Update of ablative fractionated lasers to enhance cutaneous topical drug delivery. Adv Ther 2017; 34: 1840–1849.
17. Šmucler R, Vlk M. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. Lasers Surg Med 2008; 40: 153–158.
18. Smucler R, Kriz M, Lippert J, Vlk M. Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT). Photomed Laser Surg 2012; 30: 200–205.
19. Haak C, Togsverd-Bo K, Thaysen-Petersen D et al. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas – a randomized clinical trial. Br J Dermatol 2015; 172: 215–222.
20. Lippert J, Smucler R, Vlk M. Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatol Surg 2013; 39: 1202–1208.
21. Choi S, Kim K, Song K. Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial. J Eur Acad Dermatol Venereol 2016; 30: 783–788.
22. Choi S, Kim K, Song K. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial. J Eur Acad Dermatology Venereol 2015; 29: 1598–1605.
23. 2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands. Br J Dermatol 2013; 169: 1087–1092.
24. 2 laser: a randomized clinical trial. Br J Dermatol 2012 Jun; 166: 1262–1269.
25. Ko D, Kim K, Song K. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol 2014; 170: 165–172.
26. Kim S, Park J-Y, Song H, Kim Y-S, Kim Y. Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease. Ann Dermatol 2013; 25: 335–339.
27. Sklar L, Burnett C, Waibel J, Moy R, Ozog D. Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med 2014; 46: 249–262.
28. Shokrollahi K, Javed M, Aeuyung K et al. Combined carbon dioxide laser with photodynamic therapy for nodular and superficial Basal cell carcinoma. Ann Plast Surg 2014; 73: 552–558.
29. IBM SPSS Statistics for Windows, Version 22.0. IBM Corp., Armonk, NY, 2013.
30. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2016.
31. Julious S. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005; 4: 287–291.
32. Suray A, Suriti K. Principles of office anesthesia: Part I. Infiltrative anesthesia. Am Fam Physician 2002; 66: 91–94.
33. Lehmann P. Nebenwirkungen der topischen photodynamischen therapie. Hautarzt 2007; 58: 597–603.
34. Alexiades-Armenakas M, Dover J, Arndt K. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58: 719–737.
35. Metelitsa A, Alster T. Fractionated laser skin resurfacing treatment complications: a review. Dermatologic Surg 2010; 36: 299–306.
36. Christensen E, Warloe T, Kroon S et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010; 24: 505–512.
37. Choi S, Kim K, Song K. Effect of methyl aminolevulinate photodynamic therapy with and without ablative fractional laser treatment in patients with microinvasive squamous cell carcinoma. JAMA Dermatol 2017; 153: 289.
38. Sealed Envelope Ltd. Power calculator for binary outcome equivalence trial. 2012.
39. Lee W, Shen S, Wang K, Hu C, Fang J. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci 2002; 91: 1613–1626.
40. Nguyen B, Gan S, Konnikov N, Liang C. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil. J Am Acad Dermatol 2015; 72: 558–560.
41. Hsu S, Gan S, Nguyen B, Konnikov N, Liang C. Ablative fractional laser-assisted topical fluorouracil for the treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ: a follow-up study. Dermatol Surg 2016; 42: 1050–1053.